Download the meeting's final program here
Dear Colleague:
The Cancer Research Institute hosted the 19th meeting in its International Immunotherapy Symposia Series on October 3-5, 2011, at the Millennium Conference Center in New York City. Approximately 418 immunologists and tumor immunologists from more than 200 academic institutions and biotech or pharmaceutical companies around the world attended. The meeting, entitled Immune Effector Mechanisms in Tumor Immunity, included a series of plenary lectures by leading cancer immunologists and a poster session that was open to all attendees.
The meeting focused on the following topics:
Lymphocytes and their positive and negative effects on the immune response
Veronika Groh, Fred Hutchinson Cancer Research Center, Seattle, WA
Tyler Jacks, Massachusetts Institute of Technology, Cambridge, MA
Carl H. June, University of Pennsylvania School of Medicine, Philadelphia, PA
Khashayarsha Khazaie, Northwestern University, Chicago, IL
Willem Overwijk, University of Texas MD Anderson Cancer Center, Houston, TX
Myeloid-derived cells and their positive and negative effects on the immune response
Steven M. Albelda, University of Pennsylvania School of Medicine, Philadelphia, PA
Vincenzo Bronte, Venetian Institute of Molecular Medicine, Padova, Italy
Alberto Mantovani, Mario Negri Institute, Milan, Italy
Jeffery W. Pollard, Albert Einstein College of Medicine, Bronx, NY
Irving L. Weissman, Stanford University School of Medicine, Stanford, CA
The role of antibodies
Patrick Baeuerle, Micromet, Munich, Germany
Ana Anderson, Brigham and Women's Hospital, Boston, MA
Ronald Levy, Stanford University School of Medicine, Stanford, CA
Jeffrey V. Ravetch, The Rockefeller University, New York, NY
Mark Sliwkowski, Genentech, Inc., South San Francisco, CA
Metabolism in cancer and immunity
Rafi Ahmed, Emory University, Atlanta, GA
Yongwon Choi, University of Pennsylvania School of Medicine, Philadelphia, PA
Abhijit Guha, University of Toronto, Toronto, Canada
Ross L. Levine, Memorial Sloan-Kettering Cancer Center, New York, NY
Tak W. Mak, University Health Network, Toronto, Canada
Advances in clinical immunotherapy
Charles G. Drake, Johns Hopkins University School of Medicine, Baltimore, MD
Sacha Gnjatic, Ludwig Institute for Cancer Research, NYB, New York, NY
F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA
Bruce Robinson, University of Western Australia, Perth, Australia
Paul M. Sondel, University of Wisconsin-Madison, Madison, WI
View the full agenda here. Poster abstract submission deadline was August 15, 2011.
Sincerely,
James P. Allison, Ph.D., Memorial Sloan-Kettering Cancer Center
Glenn Dranoff, M.D., Dana-Farber Cancer Institute
Carl Nathan, M.D., Weill Medical College of Cornell University
Herbert Oettgen, M.D., Memorial Sloan-Kettering Cancer Center
Lloyd J. Old, M.D., Ludwig Institute for Cancer Research
Ellen Puré, Ph.D., The Wistar Institute
Robert D. Schreiber, Ph.D., Washington University School of Medicine
Jedd Wolchok, M.D., Ph.D., Memorial Sloan-Kettering Cancer Center
Symposium Organizing Committee
|